Use of levocetirizine for the treatment of persistent allergic rhinitis

Details for Australian Patent Application No. 2003238399 (hide)

Owner UCB Farchim S.A.

Inventors Revirron, Christophe

Agent Watermark

Pub. Number AU-B-2003238399

PCT Number PCT/EP03/05491

PCT Pub. Number WO2004/050094

Priority 2080064.5 03.12.02 EP

Filing date 26 May 2003

Wipo publication date 23 June 2004

Acceptance publication date 7 May 2009

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 2080064.5 03.12.02 EP

29 July 2004 Application Open to Public Inspection

  Published as AU-B-2003238399

7 May 2009 Application Accepted

  Published as AU-B-2003238399

3 September 2009 Standard Patent Sealed

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003238400-Coating device comprising a conveying device

2003238398-METABOLITE OF 1-DIMETHYLAMINO-3-(3-METHOXY-P HENYL)-2-METHYL-PENTANE-3-OL AND THE USE THEREOF IN THE TREATMENT OF URINARY INCONTINENCE